AMGN.NASDAQAmgen INC

Form 4: Amgen CEO Robert Bradway Reports Stock Disposal for Tax Obligations

Sentiment:

SEC Form 4 Filing

📋All filings for Amgen INC
🔒Login to Follow

Amgen's CEO, Robert Bradway, disposed of 2,220 shares of common stock on May 5, 2024, to cover tax obligations.

Summary

  • On May 5, 2024, Robert A. Bradway, the Chairman, CEO, and President of Amgen Inc., disposed of 2,220 shares of Amgen common stock.
  • The transaction was executed to satisfy tax obligations.
  • The price per share was $311.29.
  • Following the transaction, Bradway beneficially owns 657,281 shares of Amgen common stock.
  • These shares include Restricted Stock Units (RSUs) that will vest on various dates in the future.
  • The shares also include Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan.

Sentiment

Score: 5

Explanation: This is a neutral filing related to a routine stock transaction for tax purposes. It doesn't indicate any positive or negative sentiment regarding the company's performance or future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard transaction related to tax obligations, which is common among executives holding company stock and equity awards.

Key Dates

DateDescription
05/05/2024Date of stock disposal transaction.
05/06/2024Date of signature on the report.
4/30/2025Vesting date for 4,516 RSUs.
5/2/2025Vesting date for 4,548 RSUs.
5/2/2026Vesting date for 4,686 RSUs and 4,450 RSUs.
5/2/2027Vesting date for 4,586 RSUs.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.